Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22McKenzie%2C+Duncan+R%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22McKenzie%2C+Duncan+R%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22McKenzie%2C+Duncan+R%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (9)
1
Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines
enthalten in:
bioRxiv.org
| 2023
von
Monin-Aldama, L.
|
Laing, A.
|
Muñoz-Ruiz, M.
| +38
Wird geladen...
2
Boosting of Waned Humoral and Cellular Responses to SARS-CoV-2 Variants of Concern Among Patients with Cancer
enthalten in:
Cancer research communications
| 2022
von
McKenzie, D.
|
Graham, R.
|
Lechmere, T.
| +16
Wird geladen...
3
A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis
enthalten in:
bioRxiv.org
| 2022
von
Laing, A.
|
Lorenc, A.
|
Del Molino Del Barrio, I.
| +45
Wird geladen...
4
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19
enthalten in:
Proceedings of the National Academy of Sciences of the United States of America
| 2022
von
Joseph, M.
|
Wu, Y.
|
Dannebaum, R.
| +38
Wird geladen...
5
Humoral and cellular immunity to delayed second dose of SARS-CoV-2 BNT162b2 mRNA vaccination in patients with cancer
enthalten in:
Cancer cell
| 2021
von
McKenzie, D.
|
Muñoz-Ruiz, M.
|
Monin, L.
| +25
Wird geladen...
6
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer : interim analysis of a prospective observational study
enthalten in:
The Lancet. Oncology
| 2021
von
Monin, L.
|
Laing, A.
|
Muñoz-Ruiz, M.
| +41
CommentIn: Lancet Oncol. 2021 Jun;22(6):738-739. - PMID 34087120
Wird geladen...
7
Author Correction : A dynamic COVID-19 immune signature includes associations with poor prognosis
enthalten in:
Nature medicine
| 2020
von
Laing, A.
|
Lorenc, A.
|
Del Molino Del Barrio, I.
| +47
ErratumFor: Nat Med. 2020 Oct;26(10):1623-1635. - PMID 32807934
Wird geladen...
8
Author Correction : A dynamic COVID-19 immune signature includes associations with poor prognosis
enthalten in:
Nature medicine
| 2020
von
Laing, A.
|
Lorenc, A.
|
Del Molino Del Barrio, I.
| +47
ErratumFor: Nat Med. 2020 Oct;26(10):1623-1635. - PMID 32807934
Wird geladen...
9
A dynamic COVID-19 immune signature includes associations with poor prognosis
enthalten in:
Nature medicine
| 2020
von
Laing, A.
|
Lorenc, A.
|
Del Molino Del Barrio, I.
| +47
ErratumIn: Nat Med. 2020 Sep 9;:. - PMID 32908251
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
9
Aufsätze
9
E-Artikel
9
E-Ressourcen
Zeitschriftentitel
3
Nature medicine
2
bioRxiv.org
1
Cancer cell
1
Cancer research communications
1
Proceedings of the National Academy of Sciences...
1
The Lancet. Oncology
Alle anzeigen ...
weniger ...
Thema
4
Journal Article
4
Research Support, Non-U.S. Gov't
3
Antibodies, Viral
2
570
2
BNT162 Vaccine
2
Biology
2
COVID-19 Vaccines
2
Cytokines
2
N38TVC63NU
2
Published Erratum
1
130068-27-8
1
CXCL10 protein, human
1
Chemokine CXCL10
1
Chemokines
1
IL10 protein, human
1
IL6 protein, human
1
Immunoglobulin G
1
Immunoglobulin Heavy Chains
1
Interleukin-10
1
Interleukin-6
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2023
3
2022
2
2021
3
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...